CP-123,369: a potent, orally active immunosuppressive agent.
Central Research Division, Pfizer Inc., Groton, CT 06340, USA.
K
K
Koch
D C
DC
Hanson
M F
MF
Newborg
K
K
Cooper
H G
HG
Fouda
M L
ML
Biehl
R M
RM
Shepard
C B
CB
Donovan
M S
MS
Biggers
M
M
Ramchandani
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000494:pharmacology
C097667:CP 123369; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016559:Tacrolimus